Penumbra, Inc. (PEN) Tops Q3 EPS by 16c, reiterates guidance

Go back to Penumbra, Inc. (PEN) Tops Q3 EPS by 16c, reiterates guidance

Penumbra (PEN) PT Raised to $241 at Deutsche Bank

October 31, 2024 5:46 AM EDT

Deutsche Bank analyst Pito Chickering raised the price target on Penumbra (NYSE: PEN) to $241.00 (from $205.00) while maintaining a Buy rating.

The analyst comments "3Q revenues of $301mm came in comfortably ahead of the Streets $297mm, equating to +11% yr/yr growth with the beat driven by upside in Thrombectomy and Embolization/Access more or less in line. Most importantly, 3Q growth in the allimportant US VTE category was a robust +32% and (coupled with NARIs solid print earlier this week) reflective of strong market growth buoyed by further share gains for... More

Penumbra (PEN) PT Lowered to $232 at BTIG

October 31, 2024 5:33 AM EDT

BTIG analyst Ryan Zimmerman lowered the price target on Penumbra (NYSE: PEN) to $232.00 (from $234.00) while maintaining a Buy rating.

The analyst comments "WHAT YOU SHOULD KNOW: We maintain our Buy but tweak our PT to $232 (from $234) following 3Q24 results. PEN reported revenue of $301.0M... More